GF
LXRX icon

Gabelli Funds’s Lexicon Pharmaceuticals LXRX Stock Holding History

Gabelli Funds’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,000
Closed -$56K – 1172
2019
Q1 		$56K Sell
10,000
-10,000
-50% -$60.7K ﹤0.01% 1120
2018
Q4 		$133K Hold
20,000
– – ﹤0.01% 1110
2018
Q3 		$213K Buy
20,000
+1,000
+5% +$11.5K ﹤0.01% 1100
2018
Q2 		$228K Buy
19,000
+1,400
+8% +$14.3K ﹤0.01% 1095
2018
Q1 		$151K Hold
17,600
– – ﹤0.01% 1120
2017
Q4 		$174K Hold
17,600
– – ﹤0.01% 1087
2017
Q3 		$216K Hold
17,600
– – ﹤0.01% 1076
2017
Q2 		$290K Hold
17,600
– – ﹤0.01% 1070
2017
Q1 		$252K Hold
17,600
– – ﹤0.01% 1076
2016
Q4 		$243K Hold
17,600
– – ﹤0.01% 1083
2016
Q3 		$318K Sell
17,600
-1,500
-8% -$24.1K ﹤0.01% 1075
2016
Q2 		$274K Hold
19,100
– – ﹤0.01% 1101
2016
Q1 		$228K Hold
19,100
– – ﹤0.01% 1085
2015
Q4 		$254K Buy
19,100
+4,815
+34% +$59.2K ﹤0.01% 1071
2015
Q3 		$153K Hold
14,285
– – ﹤0.01% 1053
2015
Q2 		$115K Sell
14,285
-1
-0% -$7 ﹤0.01% 1070
2015
Q1 		$94K Sell
14,286
-35,857
-72% -$245K ﹤0.01% 1064
2014
Q4 		$319K Sell
50,143
-14,428
-22% -$116K ﹤0.01% 1023
2014
Q3 		$637K Hold
64,571
– – ﹤0.01% 952
2014
Q2 		$728K Hold
64,571
– – ﹤0.01% 925
2014
Q1 		$782K Sell
64,571
-196,429
-75% -$2.51M ﹤0.01% 897
2013
Q4 		$3.29M Buy
261,000
+47,883
+22% +$762K 0.02% 659
2013
Q3 		$3.55M Sell
213,117
-6,282
-3% -$105K 0.02% 634
2013
Q2 		$3.33M Buy
+219,399
New +$3.33M 0.02% 614

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Gabelli Funds's LXRX Position: Q2 2019 in Review

Gabelli Funds sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2019, closing a stake of 10,000 shares — an estimated $56K sold.

Gabelli Funds first reported a position in LXRX in Q2 2013 and held it in 24 quarters. The position peaked at $3.55M in Q3 2013. 109 funds tracked by Wall St. Rank hold LXRX as of Q2 2019.

  • Gabelli Funds reported no remaining Lexicon Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Gabelli Funds sold 10,000 Lexicon Pharmaceuticals shares in Q2 2019, an estimated $56K.
  • Gabelli Funds first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • Gabelli Funds's Lexicon Pharmaceuticals position peaked at $3.55M in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2019.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.